Latest Operating Costs News

Helix Resources has boosted the inferred Mineral Resource at its Gold Basin project in Arizona to 280,000 ounces of gold, underpinning its farm-in strategy and advancing development prospects.

Lithium Universe (ASX: LU7) has launched a detailed development program to commercialise a novel hydrometallurgical process for extracting gold and copper from electronic waste, aiming to disrupt traditional smelting with a more sustainable, low-energy method.

High-Tech Metals has reported exceptional metallurgical test results from its Wagtail Gold Deposit at Mt Fisher, confirming high gold recoveries and processing flexibility that could lower costs and boost throughput.

EQ Resources has secured board approval for a A$39 million expansion at its Mt Carbine tungsten mine, aiming to double crushing capacity and boost annual production by 500 tonnes amid strong tungsten prices.

Pioneer Minerals has reopened the historic Springfield Mine Road, enabling vehicle access to its North Pine Project in Idaho and slashing exploration costs. This milestone sets the stage for accelerated fieldwork targeting tungsten, gold, and gallium.

EV Resources has locked in agreements covering more than 50% of its Tecomatlán Processing Plant's feedstock capacity through four non-binding MOUs, advancing its path to near-term antimony production amid global supply tightness.

Resouro Strategic Metals has locked in a binding agreement with Future Mining and Buri Gold to fund and operate mining and processing at its Novo Mundo gold project in Brazil, aiming to generate cash flow without diverting capital from its flagship Tiros project.

Kelsian’s Transit Systems West has locked in a two-year extension for Sydney’s Region 6 bus services, adding $500 million in revenue and advancing its electric bus fleet rollout.

Aura Energy has secured a strategic non-binding MOU with a major international nuclear utility, underpinning funding and technical collaboration for its Tiris Uranium Project in Mauritania. The company has locked in a robust processing flowsheet and aims for a Final Investment Decision by the end of 2026.

Paradigm Biopharmaceuticals has successfully raised $21.375 million through an oversubscribed Share Purchase Plan and a recent placement, bolstering its balance sheet ahead of key Phase 3 trial milestones.

Findi Limited surged revenue by 36% to $83 million for FY26 but posted a hefty $52.6 million net loss, weighed down by integration costs and capital delays. The company completed a major consolidation of its Indian financial infrastructure assets and secured $25 million in fresh capital to support growth and liquidity.

Excite Technology Services lifted revenue by 74% to $21.3 million in FY26 but still recorded a $5.4 million loss, with auditors flagging material uncertainty over its ability to continue as a going concern.